338 related articles for article (PubMed ID: 11827921)
1. T-cell-mediated lysis of endothelial cells in acute coronary syndromes.
Nakajima T; Schulte S; Warrington KJ; Kopecky SL; Frye RL; Goronzy JJ; Weyand CM
Circulation; 2002 Feb; 105(5):570-5. PubMed ID: 11827921
[TBL] [Abstract][Full Text] [Related]
2. De novo expression of killer immunoglobulin-like receptors and signaling proteins regulates the cytotoxic function of CD4 T cells in acute coronary syndromes.
Nakajima T; Goek O; Zhang X; Kopecky SL; Frye RL; Goronzy JJ; Weyand CM
Circ Res; 2003 Jul; 93(2):106-13. PubMed ID: 12816883
[TBL] [Abstract][Full Text] [Related]
3. Disparate cytotoxic activity of nickel-specific CD8+ and CD4+ T cell subsets against keratinocytes.
Traidl C; Sebastiani S; Albanesi C; Merk HF; Puddu P; Girolomoni G; Cavani A
J Immunol; 2000 Sep; 165(6):3058-64. PubMed ID: 10975816
[TBL] [Abstract][Full Text] [Related]
4. Functional subsets of CD4 T cells in rheumatoid synovitis.
Namekawa T; Wagner UG; Goronzy JJ; Weyand CM
Arthritis Rheum; 1998 Dec; 41(12):2108-16. PubMed ID: 9870867
[TBL] [Abstract][Full Text] [Related]
5. Heat-shock protein 60-reactive CD4+CD28null T cells in patients with acute coronary syndromes.
Zal B; Kaski JC; Arno G; Akiyu JP; Xu Q; Cole D; Whelan M; Russell N; Madrigal JA; Dodi IA; Baboonian C
Circulation; 2004 Mar; 109(10):1230-5. PubMed ID: 14993140
[TBL] [Abstract][Full Text] [Related]
6. Characterization of CD4+CD28null T cells in patients with coronary artery disease and individuals with risk factors for atherosclerosis.
Téo FH; de Oliveira RT; Mamoni RL; Ferreira MC; Nadruz W; Coelho OR; Fernandes Jde L; Blotta MH
Cell Immunol; 2013 Jan; 281(1):11-9. PubMed ID: 23416719
[TBL] [Abstract][Full Text] [Related]
7. Loss of CD28 within CD4
Escarra-Senmarti M; Bueno-Topete MR; Jave-Suarez LF; Gomez-Bañuelos E; Gutierrez-Franco J; Vega-Magaña N; Aguilar-Lemarroy A; Pereira-Suarez AL; Haramati J; Del Toro-Arreola S
Immunol Lett; 2017 Feb; 182():30-38. PubMed ID: 28087292
[TBL] [Abstract][Full Text] [Related]
8. Differential pathways govern CD4+ CD28- T cell proinflammatory and effector responses in patients with coronary artery disease.
Zal B; Kaski JC; Akiyu JP; Cole D; Arno G; Poloniecki J; Madrigal A; Dodi A; Baboonian C
J Immunol; 2008 Oct; 181(8):5233-41. PubMed ID: 18832677
[TBL] [Abstract][Full Text] [Related]
9. Essential roles of perforin in antigen-specific cytotoxicity mediated by human CD4+ T lymphocytes: analysis using the combination of hereditary perforin-deficient effector cells and Fas-deficient target cells.
Yanai F; Ishii E; Kojima K; Hasegawa A; Azuma T; Hirose S; Suga N; Mitsudome A; Zaitsu M; Ishida Y; Shirakata Y; Sayama K; Hashimoto K; Yasukawa M
J Immunol; 2003 Feb; 170(4):2205-13. PubMed ID: 12574394
[TBL] [Abstract][Full Text] [Related]
10. Perforin expression can define CD8 positive lymphocyte subsets in pigs allowing phenotypic and functional analysis of natural killer, cytotoxic T, natural killer T and MHC un-restricted cytotoxic T-cells.
Denyer MS; Wileman TE; Stirling CM; Zuber B; Takamatsu HH
Vet Immunol Immunopathol; 2006 Apr; 110(3-4):279-92. PubMed ID: 16325923
[TBL] [Abstract][Full Text] [Related]
11. Differentiation of human CD8 T cells: implications for in vivo persistence of CD8+ CD28- cytotoxic effector clones.
Posnett DN; Edinger JW; Manavalan JS; Irwin C; Marodon G
Int Immunol; 1999 Feb; 11(2):229-41. PubMed ID: 10069421
[TBL] [Abstract][Full Text] [Related]
12. Monoclonal T-cell proliferation and plaque instability in acute coronary syndromes.
Liuzzo G; Goronzy JJ; Yang H; Kopecky SL; Holmes DR; Frye RL; Weyand CM
Circulation; 2000 Jun; 101(25):2883-8. PubMed ID: 10869258
[TBL] [Abstract][Full Text] [Related]
13. Cytomegalovirus-Associated CD4(+) CD28(null) Cells in NKG2D-Dependent Glomerular Endothelial Injury and Kidney Allograft Dysfunction.
Shabir S; Smith H; Kaul B; Pachnio A; Jham S; Kuravi S; Ball S; Chand S; Moss P; Harper L; Borrows R
Am J Transplant; 2016 Apr; 16(4):1113-28. PubMed ID: 26603521
[TBL] [Abstract][Full Text] [Related]
14. CD4+,CD28- T cells in rheumatoid arthritis patients combine features of the innate and adaptive immune systems.
Warrington KJ; Takemura S; Goronzy JJ; Weyand CM
Arthritis Rheum; 2001 Jan; 44(1):13-20. PubMed ID: 11212151
[TBL] [Abstract][Full Text] [Related]
15. High levels of costimulatory receptors OX40 and 4-1BB characterize CD4+CD28null T cells in patients with acute coronary syndrome.
Dumitriu IE; Baruah P; Finlayson CJ; Loftus IM; Antunes RF; Lim P; Bunce N; Kaski JC
Circ Res; 2012 Mar; 110(6):857-69. PubMed ID: 22282196
[TBL] [Abstract][Full Text] [Related]
16. Unusual CD4+CD28null T lymphocytes and recurrence of acute coronary events.
Liuzzo G; Biasucci LM; Trotta G; Brugaletta S; Pinnelli M; Digianuario G; Rizzello V; Rebuzzi AG; Rumi C; Maseri A; Crea F
J Am Coll Cardiol; 2007 Oct; 50(15):1450-8. PubMed ID: 17919564
[TBL] [Abstract][Full Text] [Related]
17. Expression of perforin and membrane-bound lymphotoxin (tumor necrosis factor-beta) in virus-specific CD4+ human cytotoxic T-cell clones.
Yasukawa M; Yakushijin Y; Hasegawa H; Miyake M; Hitsumoto Y; Kimura S; Takeuchi N; Fujita S
Blood; 1993 Mar; 81(6):1527-34. PubMed ID: 8095828
[TBL] [Abstract][Full Text] [Related]
18. Localization of Fas ligand in cytoplasmic granules of CD8+ cytotoxic T lymphocytes and natural killer cells: participation of Fas ligand in granule exocytosis model of cytotoxicity.
Kojima Y; Kawasaki-Koyanagi A; Sueyoshi N; Kanai A; Yagita H; Okumura K
Biochem Biophys Res Commun; 2002 Aug; 296(2):328-36. PubMed ID: 12163021
[TBL] [Abstract][Full Text] [Related]
19. Multiple cytolytic mechanisms displayed by activated human peripheral blood T cell subsets.
Smyth MJ; Norihisa Y; Ortaldo JR
J Immunol; 1992 Jan; 148(1):55-62. PubMed ID: 1345790
[TBL] [Abstract][Full Text] [Related]
20. MRL/lpr CD4- CD8- and CD8+ T cells, respectively, mediate Fas-dependent and perforin cytotoxic pathways.
Benihoud K; Bonardelle D; Bobé P; Kiger N
Eur J Immunol; 1997 Feb; 27(2):415-20. PubMed ID: 9045912
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
